This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.
Modern Engineering Marvels on MSN
CRISPRi unveils tuberculosis’ fatal respiratory weak point
A disease that has stalked humanity for millennia may have finally met its match. Mycobacterium tuberculosis, the pathogen ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...
New gene-editing tools – most notably the Nobel Prize-winning CRISPR-Cas9 – allow targeted tweaks to a crop’s genome, ...
Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...
When blood cancer in children progresses particularly aggressively, it is often due to a genetic defect: a gene fusion, such ...
From custom gene editing to a discovery that could help stop pancreatic cancer before it starts, these advances offer a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback